According to the World Health Organization, about 422 million people worldwide have diabetes, and 1.5 million deaths are directly attributed to it each year. To better understand the nuances and factors contributing to the disease and its complications, IHH Malaysia became the first Platinum Sponsor of the Seremban Diabetes (SeDia) Cohort Study in Malaysia, with a contribution of RM 2 million.
Jean-François Naa, CEO of IHH Malaysia, presented a mock cheque at the launch of the longitudinal study by the Ministry of Health and International Medical University on 08 July 2023.
The SeDia Cohort Study will encompass a comprehensive examination of various factors, from genetics and family history of diabetes to lifestyle and environmental factors, dietary regimes, physical activity, socio-economic levels and healthcare delivery. By understanding the complex connections between these factors, the aim is to uncover optimal strategies for diabetes prevention and treatment.
Subsequently, this knowledge can be translated into evidence-based public healthcare policies and programmes that are relevant to the local community. This ensures the efficacy of developed treatment and prevention initiatives in addressing the escalating burden of diabetes in Malaysia.
This 12-year study marks the first important step towards obtaining data that is socio-culturally relevant to the local community. It involves over 5,000 patients registered as part of the Klinik Kesihatan Seremban’s Diabetes Registry and over 7,000 of their family members, to investigate the complex web of interactions that contribute to the development of diabetes and its complications.
Related Stories
IHH Healthcare Advocates Long-term Sustainability Thinking at Future Economy Conference
At the recent Future Economy Conference 2026, IHH's Group Chief Sustainability Officer Yasemin Tecmen Stubbe shared why sustainability remains critical to business resilience and long-term value creation, particularly amid growing geopolitical uncertainty, climate risks and supply chain disruptions.
IHH Healthcare Aligns Teams in Malaysia and Singapore on Future-ready Healthcare Priorities
IHH Healthcare recently brought together employees across Malaysia’s Southern Region and Singapore for its Country Town Halls, reinforcing the Group’s focus on strengthening current healthcare capabilities while preparing for the evolving needs of the future.
Gleneagles Hong Kong and HKTDC Co-organised a Thematic Session at The Asia Summit on Global Health 2026
Titled “Intelligence at Scale: How AI is Powering Real-World Healthcare Revolution”, the thematic panel session co-organised by Gleneagles Hong Kong and Hong Kong Trade Development Council (HKTDC) was moderated by Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia.
Acibadem Performed Türkiye's First Experimental 5G‑Supported Remote Robotic Surgical Simulation
The simulation was conducted between Acibadem Maslak Hospital and Acibadem University CASE (Advanced Medical Simulation and Training Center).
Parkway Rehab Supports Children’s Aid Society Through Project Legacy
At Parkway Rehab, while clinical care remains at the heart of the organisation, the team believes in looking beyond daily practice - to contribute meaningfully to the community, supporting those in need, within available means, and with purpose.
Gleneagles JPMC performs first VARIPULSE procedure in Borneo
Cardiovascular Laboratory at Gleneagles JPMC continues to evolve, marked by new milestones in advanced heart rhythm procedures.
